AvalehtAZN • NASDAQ
add
AstraZeneca
Viimane sulgemishind
76,87 $
Tänane vahemik
76,95 $ - 77,36 $
Aasta vahemik
60,48 $ - 87,67 $
Turuväärtus
239,76 mld USD
Keskmine maht
4,36 mln
Uudised
Finantsandmed
Kasumiaruanne
Käive
Puhastulu
(USD) | juuni 2024info | Y/Y muutus |
---|---|---|
Käive | 12,94 mld | 13,33% |
Põhitegevusega seonduv kulu | 7,87 mld | 12,44% |
Puhastulu | 1,93 mld | 6,00% |
Puhaskasumimarginaal | 14,89 | −6,53% |
Puhaskasum aktsia kohta | 1,98 | 84,19% |
EBITDA | 4,15 mld | 12,76% |
Tõhus maksumäär | 19,57% | — |
Bilansiaruanne
Kogu vara
Kõik kohustused
(USD) | juuni 2024info | Y/Y muutus |
---|---|---|
Sularaha ja lühiajalised investeeringud | 7,08 mld | 21,75% |
Kogu vara | 104,34 mld | 8,08% |
Kõik kohustused | 64,74 mld | 9,50% |
Kogu omakapital | 39,60 mld | — |
Emiteeritud aktsiate arv | 1,55 mld | — |
Hinna ja väärtuse suhe P/B | 3,02 | — |
Varade tasuvus | 7,02% | — |
Kapitali tasuvus | 9,97% | — |
Rahavoog
Raha ja raha ekvivalentide muutus
(USD) | juuni 2024info | Y/Y muutus |
---|---|---|
Puhastulu | 1,93 mld | 6,00% |
Põhitegevuse rahakäive | 3,08 mld | 79,57% |
Investeeringute raha | −2,87 mld | −452,31% |
Finantseerimise raha | −1,22 mld | 19,55% |
Raha ja raha ekvivalentide muutus | −1,02 mld | −184,31% |
Tasuta rahavoog | 2,05 mld | 52,92% |
Teave
AstraZeneca plc is a British-Swedish multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England. It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation. It was involved in developing the Oxford–AstraZeneca COVID-19 vaccine.
The company was founded in 1999 through the merger of the Swedish Astra AB and the British Zeneca Group. Since the merger it has been among the world's largest pharmaceutical companies and has made numerous corporate acquisitions, including Cambridge Antibody Technology, MedImmune, Spirogen and Definiens. It has its research and development concentrated in three strategic centres: Cambridge, England; Gothenburg, Sweden and Gaithersburg in Maryland, U.S.
AstraZeneca traces its earliest corporate history to 1913, when Astra AB was formed by a large group of doctors and apothecaries in Södertälje. Throughout the twentieth century, it grew into the largest pharmaceutical company in Sweden. Wikipedia
Tegevjuht
Asutatud
6. apr 1999
Veebisait
Töötajate arv
89 900